Skip header and navigation

2 records – page 1 of 1.

Barriers, supports, and effective interventions for uptake of human papillomavirus- and other vaccines within global and Canadian Indigenous peoples: a systematic review protocol.

https://arctichealth.org/en/permalink/ahliterature290200
Source
Syst Rev. 2018 Mar 02; 7(1):40
Publication Type
Journal Article
Date
Mar-02-2018
Author
Kelly J Mrklas
Shannon MacDonald
Melissa A Shea-Budgell
Nancy Bedingfield
Heather Ganshorn
Sarah Glaze
Lea Bill
Bonnie Healy
Chyloe Healy
Juliet Guichon
Amy Colquhoun
Christopher Bell
Ruth Richardson
Rita Henderson
James Kellner
Cheryl Barnabe
Robert A Bednarczyk
Angeline Letendre
Gregg S Nelson
Author Affiliation
Research Innovation and Analytics, Alberta Health Services, Edmonton, Canada.
Source
Syst Rev. 2018 Mar 02; 7(1):40
Date
Mar-02-2018
Language
English
Publication Type
Journal Article
Abstract
Despite the existence of human papilloma virus (HPV) vaccines with demonstrated safety and effectiveness and funded HPV vaccination programs, coverage rates are persistently lower and cervical cancer burden higher among Canadian Indigenous peoples. Barriers and supports to HPV vaccination in Indigenous peoples have not been systematically documented, nor have interventions to increase uptake in this population. This protocol aims to appraise the literature in Canadian and global Indigenous peoples, relating to documented barriers and supports to vaccination and interventions to increase acceptability/uptake or reduce hesitancy of vaccination. Although HPV vaccination is the primary focus, we anticipate only a small number of relevant studies to emerge from the search and will, therefore, employ a broad search strategy to capture literature related to both HPV vaccination and vaccination in general in global Indigenous peoples.
Eligible studies will include global Indigenous peoples and discuss barriers or supports and/or interventions to improve uptake or to reduce hesitancy, for the HPV vaccine and/or other vaccines. Primary outcomes are documented barriers or supports or interventions. All study designs meeting inclusion criteria will be considered, without restricting by language, location, or data type. We will use an a priori search strategy, comprised of key words and controlled vocabulary terms, developed in consultation with an academic librarian, and reviewed by a second academic librarian using the PRESS checklist. We will search several electronic databases from date of inception, without restrictions. A pre-defined group of global Indigenous websites will be reviewed for relevant gray literature. Bibliographic searches will be conducted for all included studies to identify relevant reviews. Data analysis will include an inductive, qualitative, thematic synthesis and a quantitative analysis of measured barriers and supports, as well as a descriptive synthesis and quantitative summary of measures for interventions.
To our knowledge, this study will contribute the first systematic review of documented barriers, supports, and interventions for vaccination in general and for HPV vaccination. The results of this study are expected to inform future research, policies, programs, and community-driven initiatives to enhance acceptability and uptake of HPV vaccination among Indigenous peoples.
PROSPERO Registration Number: CRD42017048844.
Notes
Cites: Lancet Oncol. 2012 Jun;13(6):607-15 PMID 22575588
Cites: Vaccine. 2016 Aug 17;34(37):4371-7 PMID 27443591
Cites: N Engl J Med. 2015 Feb 19;372(8):711-23 PMID 25693011
Cites: Vaccine. 2015 Aug 14;33(34):4161-4 PMID 25896383
Cites: J Community Health. 2014 Jun;39(3):409-15 PMID 24276617
Cites: Int J Cancer. 2015 Feb 1;136(3):639-45 PMID 24923728
Cites: Lancet Oncol. 2015 Nov;16(15):1483-1492 PMID 26476758
Cites: Ethn Dis. 2011 Summer;21(3):335-41 PMID 21942167
Cites: Vaccine. 2013 Oct 25;31(45):5152-67 PMID 24029117
Cites: BMJ. 2017 Mar 6;356:i6795 PMID 28264797
Cites: Vaccine. 2010 Jun 11;28(26):4235-48 PMID 20438879
Cites: Vaccine. 2013 Oct 1;31(42):4848-55 PMID 23933332
Cites: Vaccine. 2012 May 21;30(24):3546-56 PMID 22480928
Cites: Implement Sci. 2011 Apr 23;6:42 PMID 21513547
Cites: Ann Fam Med. 2007 Jul-Aug;5(4):298-304 PMID 17664495
Cites: Vaccine. 2016 Feb 3;34(6):703-13 PMID 26742947
Cites: Prev Med. 2007 Aug-Sep;45(2-3):107-14 PMID 17628649
Cites: Cancer Epidemiol Biomarkers Prev. 2011 Nov;20(11):2354-61 PMID 21949110
Cites: Hum Vaccin Immunother. 2013 Aug;9(8):1763-73 PMID 23584253
Cites: Syst Rev. 2015 Jan 01;4:1 PMID 25554246
Cites: Prev Med. 2014 Jan;58:22-32 PMID 24176938
Cites: Annu Rev Public Health. 2014;35:29-45 PMID 24188053
Cites: Infect Agent Cancer. 2013 Jul 01;8(1):25 PMID 23816397
Cites: J Infect Public Health. 2011 Nov;4(5-6):219-27 PMID 22118716
Cites: J Clin Epidemiol. 2005 Nov;58(11):1081-8 PMID 16223649
Cites: Gynecol Oncol. 2009 Aug;114(2):360-4 PMID 19410282
Cites: Implement Sci. 2009 Aug 07;4:50 PMID 19664226
Cites: Am J Prev Med. 2000 Jan;18(1 Suppl):44-74 PMID 10806979
Cites: MMWR Morb Mortal Wkly Rep. 2016 Oct 07;65(39):1065-1071 PMID 27711036
Cites: Can J Public Health. 2007 Sep-Oct;98(5):417-21 PMID 17985687
Cites: Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3141-9 PMID 18990756
Cites: Vaccine. 2015 Jun 26;33(29):3377-83 PMID 26003493
Cites: Vaccine. 2015 Aug 14;33(34):4176-9 PMID 25896376
Cites: CMAJ. 2012 Oct 16;184(15):1673-81 PMID 22966054
Cites: JAMA Pediatr. 2015 Jul;169(7):686-92 PMID 26010507
Cites: Am J Prev Med. 2000 Jan;18(1 Suppl):35-43 PMID 10806978
Cites: J Clin Epidemiol. 2016 May;73:29-35 PMID 26891948
Cites: Acta Oncol. 1996;35(5):581-7 PMID 8813065
Cites: JAMA. 2002 Jun 5;287(21):2831-4 PMID 12038926
Cites: Am J Public Health. 2000 Sep;90(9):1466-8 PMID 10983210
Cites: Cochrane Database Syst Rev. 2015 Apr 29;(4):CD005470 PMID 25923419
Cites: N Engl J Med. 2003 Feb 6;348(6):518-27 PMID 12571259
Cites: Public Health Rep. 2007 Mar-Apr;122(2):248-57 PMID 17357368
Cites: Vaccine. 2014 Apr 17;32(19):2150-9 PMID 24598724
Cites: Health Technol Assess. 2004 Feb;8(6):iii-iv, 1-72 PMID 14960256
Cites: Womens Health Issues. 2012 Jul-Aug;22(4):e379-86 PMID 22609253
Cites: Bull World Health Organ. 2008 Feb;86(2):140-6 PMID 18297169
Cites: Vaccine. 2011 Jan 29;29(5):890-5 PMID 20056186
Cites: Int J Epidemiol. 2013 Jun;42(3):896-908 PMID 23620381
Cites: Cancer Prev Res (Phila). 2015 Jan;8(1):49-55 PMID 25403849
Cites: Sex Transm Infect. 2013 Nov;89(7):568-74 PMID 23828943
Cites: Am J Public Health. 2003 Dec;93(12):2046-9 PMID 14652331
Cites: BMC Infect Dis. 2013 Aug 31;13:403 PMID 24004727
Cites: BMC Med Res Methodol. 2008 Jul 10;8:45 PMID 18616818
Cites: BMC Public Health. 2014 Jul 09;14:700 PMID 25004868
Cites: Int Q Community Health Educ. 2013-2014;34(1):101-17 PMID 24366025
Cites: Curr Med Res Opin. 2008 Jun;24(6):1719-41 PMID 18474148
Cites: Ann Intern Med. 2009 Aug 18;151(4):264-9, W64 PMID 19622511
Cites: Int J Circumpolar Health. 2008 Dec;67(5):408-20 PMID 19186762
Cites: Gynecol Oncol. 2014 Mar;132 Suppl 1:S9-12 PMID 24384459
Cites: Vaccine. 2016 Apr 4;34(15):1800-5 PMID 26921782
Cites: Acad Emerg Med. 2007 Nov;14(11):936-41 PMID 17967955
Cites: Arch Pediatr Adolesc Med. 2005 May;159(5):470-6 PMID 15867122
Cites: Cancer. 2016 May 15;122(10 ):1560-9 PMID 27149550
Cites: J Eval Clin Pract. 2012 Aug;18(4):746-52 PMID 21410846
Cites: Implement Sci. 2012 Apr 24;7:38 PMID 22531013
Cites: Pediatrics. 2016 Jul;138(1):null PMID 27296865
Cites: Vaccine. 2014 Apr 7;32(17):1901-20 PMID 24530401
Cites: Sex Transm Dis. 2015 May;42(5):272-8 PMID 25868140
Cites: JAMA Pediatr. 2014 Jan;168(1):76-82 PMID 24276343
Cites: Pediatr Infect Dis J. 2016 Jun;35(6):e177-9 PMID 26954603
Cites: Int J STD AIDS. 2010 Aug;21(8):558-62 PMID 20975088
Cites: Cochrane Database Syst Rev. 2010 Mar 17;(3):CD005470 PMID 20238340
Cites: J Am Coll Health. 2014;62(1):32-8 PMID 24313694
Cites: BMC Med Res Methodol. 2012 Nov 27;12:181 PMID 23185978
Cites: Vaccine. 2011 Dec 6;29(52):9588-99 PMID 22033031
Cites: J Clin Epidemiol. 2016 May;73:43-9 PMID 26912124
Cites: Paediatr Child Health. 2007 Dec;12(10):847-52 PMID 19043498
Cites: Vaccine. 2015 Aug 14;33(34):4191-203 PMID 25896385
Cites: BMC Public Health. 2016 Nov 14;16(1):1159 PMID 27842585
Cites: Implement Sci. 2014 Oct 06;9:152 PMID 25287951
Cites: J Contin Educ Health Prof. 2006 Winter;26(1):13-24 PMID 16557505
Cites: BMC Med Res Methodol. 2012 Aug 03;12:114 PMID 22862833
Cites: Vaccine. 2013 Sep 13;31(40):4293-304 PMID 23859839
Cites: Prev Med. 2015 Dec;81:122-31 PMID 26314783
Cites: J Clin Epidemiol. 2009 Sep;62(9):944-52 PMID 19230612
Cites: Med J Aust. 2013 Nov 4;199(9):614-7 PMID 24182228
Cites: Int J Circumpolar Health. 2008 Dec;67(5):445-51 PMID 19186765
PubMed ID
29499749 View in PubMed
Less detail

Barriers, supports, and effective interventions for uptake of human papillomavirus- and other vaccines within global and Canadian Indigenous peoples: a systematic review protocol.

https://arctichealth.org/en/permalink/ahliterature296896
Source
Syst Rev. 2018 03 02; 7(1):40
Publication Type
Journal Article
Research Support, Non-U.S. Gov't
Review
Date
03-02-2018
Author
Kelly J Mrklas
Shannon MacDonald
Melissa A Shea-Budgell
Nancy Bedingfield
Heather Ganshorn
Sarah Glaze
Lea Bill
Bonnie Healy
Chyloe Healy
Juliet Guichon
Amy Colquhoun
Christopher Bell
Ruth Richardson
Rita Henderson
James Kellner
Cheryl Barnabe
Robert A Bednarczyk
Angeline Letendre
Gregg S Nelson
Author Affiliation
Research Innovation and Analytics, Alberta Health Services, Edmonton, Canada.
Source
Syst Rev. 2018 03 02; 7(1):40
Date
03-02-2018
Language
English
Publication Type
Journal Article
Research Support, Non-U.S. Gov't
Review
Keywords
Canada
Female
Health Services, Indigenous
Humans
Papillomavirus Infections - prevention & control
Papillomavirus Vaccines - administration & dosage
Patient Acceptance of Health Care - ethnology
Population Groups - ethnology
Uterine Cervical Neoplasms - prevention & control
Vaccination
Abstract
Despite the existence of human papilloma virus (HPV) vaccines with demonstrated safety and effectiveness and funded HPV vaccination programs, coverage rates are persistently lower and cervical cancer burden higher among Canadian Indigenous peoples. Barriers and supports to HPV vaccination in Indigenous peoples have not been systematically documented, nor have interventions to increase uptake in this population. This protocol aims to appraise the literature in Canadian and global Indigenous peoples, relating to documented barriers and supports to vaccination and interventions to increase acceptability/uptake or reduce hesitancy of vaccination. Although HPV vaccination is the primary focus, we anticipate only a small number of relevant studies to emerge from the search and will, therefore, employ a broad search strategy to capture literature related to both HPV vaccination and vaccination in general in global Indigenous peoples.
Eligible studies will include global Indigenous peoples and discuss barriers or supports and/or interventions to improve uptake or to reduce hesitancy, for the HPV vaccine and/or other vaccines. Primary outcomes are documented barriers or supports or interventions. All study designs meeting inclusion criteria will be considered, without restricting by language, location, or data type. We will use an a priori search strategy, comprised of key words and controlled vocabulary terms, developed in consultation with an academic librarian, and reviewed by a second academic librarian using the PRESS checklist. We will search several electronic databases from date of inception, without restrictions. A pre-defined group of global Indigenous websites will be reviewed for relevant gray literature. Bibliographic searches will be conducted for all included studies to identify relevant reviews. Data analysis will include an inductive, qualitative, thematic synthesis and a quantitative analysis of measured barriers and supports, as well as a descriptive synthesis and quantitative summary of measures for interventions.
To our knowledge, this study will contribute the first systematic review of documented barriers, supports, and interventions for vaccination in general and for HPV vaccination. The results of this study are expected to inform future research, policies, programs, and community-driven initiatives to enhance acceptability and uptake of HPV vaccination among Indigenous peoples.
PROSPERO Registration Number: CRD42017048844.
PubMed ID
29499749 View in PubMed
Less detail